文献速递神经肿瘤

RUNX3通过抑制β-catenin/TCF-4信号通路抑制胶质瘤生存与侵袭

RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway.
PubMed 文献 · J Neurooncol · 2018-06-18

该研究通过组织芯片、冰冻肿瘤组织和胶质瘤细胞系检测RUNX3表达,并用功能实验确认其作用。结果发现强制表达RUNX3可在体外和体内抑制增殖与侵袭、诱导细胞周期阻滞并促进凋亡,Bim siRNA可部分逆转RUNX3诱导的凋亡;机制上RUNX3抑制β-catenin/Tcf-4转录活性。结论认为RUNX3作为抑癌因子通过减弱Wnt信号在胶质瘤发生进展中起关键作用,是潜在治疗靶点。

要点

  • 强制表达RUNX3在体外和体内抑制胶质瘤增殖与侵袭,诱导细胞周期阻滞并促进凋亡。
  • Bim siRNA可部分逆转RUNX3诱导的LN229和U87细胞凋亡,提示依赖Bim-caspase通路。
  • RUNX3抑制β-catenin/Tcf-4转录活性,作为抑癌因子通过减弱Wnt信号发挥作用。

核心结论

  • RUNX3作为抑癌因子通过减弱Wnt信号在胶质瘤发生和进展中起关键作用,是潜在治疗靶点。

研究设计与样本

  • 用组织芯片、冰冻肿瘤组织和恶性胶质瘤细胞系,通过免疫组化、qRT-PCR和Western bolt检测RUNX3表达。
  • 检测细胞增殖、侵袭、细胞周期分布和凋亡以确认RUNX3介导的恶性表型效应。
  • 用TOP/FOP实验检测RUNX3对β-catenin/Tcf-4转录活性的影响。

主要发现

  • 强制表达RUNX3在体外和体内抑制增殖与侵袭,诱导细胞周期阻滞并促进凋亡。
  • Bim siRNA部分逆转RUNX3诱导的LN229和U87细胞凋亡,提示依赖Bim-caspase通路。
  • 机制研究显示恢复RUNX3可抑制β-catenin/Tcf-4转录活性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Runt-related transcription factor 3 (RUNX3) exerts a tumor suppressor gene associated with gastric and other cancers, including glioma. However, how its anti-tumor mechanism in functions glioma is unclear. METHODS: We assayed expression of RUNX3 with a tissue microarray (TMA), frozen cancer tissues and malignant glioma cell lines using immunohistochemistry, qRT-PCR and Western bolt analysis. Cell proliferation, invasion, cell cycle distribution and apoptosis were also examined to confirm the effect of RUNX3 medicated malignant phenotype. TOP/FOP experiment was used to detect the β-catenin/Tcf-4 transcription activity by RUNX3. RESULTS: Enforced RUNX3 expression inhibited proliferation and invasion, induced cell cycle arrest and promoted apoptosis in vitro and in vivo, Bim siRNA partically reversed the effect of RUNX3-induced apoptosis in LN229 and U87 cells, suggesting a dependent role of Bim-caspase pathway. Moreover, Mechanism investigations revealed that restoration of RUNX3 suppressed β-catenin/Tcf-4 transcription activity. CONCLUSIONS: RUNX3 plays a pivotal role in glioma initiation and progression as a tumor suppressor via attenuation of Wnt signaling, highlighting it as a potential therapeutic target for glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Sun J, Li B, Jia Z, et al. RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway. J Neurooncol. 2018. PMID: 29916101. doi:10.1007/s11060-018-2927-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。